Diaceutics Plc (DXRX) Ord GBP0.002
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Diaceutics reports progress with rare-disease offerings
27 August 2024 12:24
(Sharecast News) - Diaceutics announced a significant enhancement to its rare-disease offerings on Tuesday, leading to the acquisition of a new contract aimed at supporting the commercialisation of a...
-
Diaceutics strikes 'groundbreaking' enterprise promotional partnership
19 August 2024 08:11
(Sharecast News) - Technology and solutions provider Diaceutics has struck a "groundbreaking enterprise promotional partnership" with a "leading biotech" firm worth up to £4.3m over 18...
-
Diaceutics strikes two new enterprise-wide agreements
16 May 2024 10:09
(Sharecast News) - Technology and solutions provider Diaceutics has struck two new enterprise-wide agreements, taking the total number to six engagements, across 29 separate therapeutic brands.
-
Diaceutics appoints new VP of marketing
9 April 2024 12:34
(Sharecast News) - Diaceutics, a technology and solutions provider catering to the pharmaceutical and biotech industry, announced the appointment of Amie Mc Neice as vice-president of marketing on Tuesday.
-
Director dealings: BAT, Diaceutics execs make investments
6 June 2023 13:47
(Sharecast News) - Among the list of director buys on Tuesday was British American Tobacco, after its chief executive picked up more than a quarter-of-a-million pounds worth of shares.
-
Diaceutics shares resume trading after HSBC buys SVB UK
13 March 2023 11:10
(Sharecast News) - Pharmaceutical technology and service provider Diaceutics announced at mid-morning on Monday that the temporary suspension of its shares on AIM would be lifted.
-
Diaceutics secures $2m multi-year contract with global pharma company
13 June 2022 10:30
(Sharecast News) - Diagnostic commercialisation company Diaceutics has secured a multi-year contract win with an unnamed "top five" global pharmaceutical company to deliver customised data insights...
-
Diaceutics inks five-year deal with existing pharma partner
5 May 2022 12:58
(Sharecast News) - Diaceutics announced a five-year, multi-product subscription contract with an unnamed "top 30" global pharma company on Thursday, to deliver customised data insights via its...
-
Diaceutics secures $1m subscription contract with 'leading life sciences company'
14 December 2021 09:45
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Tuesday that it had secured a $1.0m contract with a "leading life sciences company" to provide data feed from its DXRX...
Company announcements Announcements
-
Capital Markets Webinar
5 November 2024 07:00
Diaceutics
-
Holding(s) in Company
4 November 2024 07:00
Diaceutics
-
PDMR Shareholding/Share Incentive Plan
30 October 2024 14:58
Diaceutics
-
Board Change Update
29 October 2024 10:27
Diaceutics
-
Issue of Share Options/PDMR Shareholdings
25 October 2024 07:00
Diaceutics
-
Cancellation of Share Premium Account
24 October 2024 12:53
Diaceutics
-
Holding(s) in Company
7 October 2024 13:19
Diaceutics
-
Block Listing Return
7 October 2024 07:00
Diaceutics
-
PDMR Shareholding/Share Incentive Plan
2 October 2024 07:00
Diaceutics
-
Board Changes
1 October 2024 07:00
Diaceutics
-
H1 2024 Results - Continued Performance & Growth
17 September 2024 07:00
Diaceutics
-
Appointment of Nominated Adviser and Broker
2 September 2024 07:00
Diaceutics
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.